Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors

Figure 2

The chemical structures of antioxidant molecules that are used or could be used for the treatment of the intermediate form of AMD.

(a)

(b)

(c)

(d)

(e)

(f)